{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T08:34:22Z","timestamp":1771922062378,"version":"3.50.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s11011-019-00425-0","type":"journal-article","created":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T06:30:09Z","timestamp":1559370609000},"page":"1023-1027","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Autosomal dominant optic atrophy plus due to the novel OPA1 variant c.1463G>C"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2839-7305","authenticated-orcid":false,"given":"Josef","family":"Finsterer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franco","family":"Laccone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,6,1]]},"reference":[{"key":"425_CR1","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1007\/s00415-015-7849-6","volume":"262","author":"KE Ahmad","year":"2015","unstructured":"Ahmad KE, Davis RL, Sue CM (2015) A novel OPA1 mutation causing variable age of onset autosomal dominant optic atrophy plus in an Australian family. J Neurol 262:2323\u20132328","journal-title":"J Neurol"},{"key":"425_CR2","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1093\/brain\/awm298","volume":"131","author":"P Amati-Bonneau","year":"2008","unstructured":"Amati-Bonneau P, Valentino ML, Reynier P, Gallardo ME, Bornstein B, Boissi\u00e8re A, Campos Y, Rivera H, de la Aleja JG, Carroccia R, Iommarini L, Labauge P, Figarella-Branger D, Marcorelles P, Furby A, Beauvais K, Letournel F, Liguori R, La Morgia C, Montagna P, Liguori M, Zanna C, Rugolo M, Cossarizza A, Wissinger B, Verny C, Schwarzenbacher R, Mart\u00edn MA, Arenas J, Ayuso C, Garesse R, Lenaers G, Bonneau D, Carelli V (2008) OPA1 mutations induce mitochondrial DNA instability and optic atrophy 'plus' phenotypes. Brain 131:338\u2013351","journal-title":"Brain"},{"key":"425_CR3","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/ana.24410","volume":"78","author":"V Carelli","year":"2015","unstructured":"Carelli V, Musumeci O, Caporali L, Zanna C, La Morgia C, Del Dotto V, Porcelli AM, Rugolo M, Valentino ML, Iommarini L, Maresca A, Barboni P, Carbonelli M, Trombetta C, Valente EM, Patergnani S, Giorgi C, Pinton P, Rizzo G, Tonon C, Lodi R, Avoni P, Liguori R, Baruzzi A, Toscano A, Zeviani M (2015) Syndromic parkinsonism and dementia associated with OPA1 missense mutations. Ann Neurol 78:21\u201338","journal-title":"Ann Neurol"},{"key":"425_CR4","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/79936","volume":"26","author":"C Delettre","year":"2000","unstructured":"Delettre C, Lenaers G, Griffoin JM, Gigarel N, Lorenzo C, Belenguer P, Pelloquin L, Grosgeorge J, Turc-Carel C, Perret E, Astarie-Dequeker C, Lasquellec L, Arnaud B, Ducommun B, Kaplan J, Hamel CP (2000) Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy. Nat Genet 26:207\u2013210","journal-title":"Nat Genet"},{"key":"425_CR5","doi-asserted-by":"publisher","first-page":"37972","DOI":"10.1074\/jbc.M606059200","volume":"281","author":"S Duvezin-Caubet","year":"2006","unstructured":"Duvezin-Caubet S, Jagasia R, Wagener J, Hofmann S, Trifunovic A, Hansson A, Chomyn A, Bauer MF, Attardi G, Larsson NG, Neupert W, Reichert AS (2006) Proteolytic processing of OPA1 links mitochondrial dysfunction to alterations in mitochondrial morphology. J Biol Chem 281:37972\u201337979","journal-title":"J Biol Chem"},{"key":"425_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mito.2017.10.003","volume":"42","author":"J Finsterer","year":"2018","unstructured":"Finsterer J, Mancuso M, Pareyson D, Burgunder JM, Klopstock T (2018) Mitochondrial disorders of the retinal ganglion cells and the optic nerve. Mitochondrion 42:1\u201310","journal-title":"Mitochondrion"},{"key":"425_CR7","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1093\/brain\/awx219","volume":"140","author":"S Gerber","year":"2017","unstructured":"Gerber S, Charif M, Chevrollier A, Chaumette T, Angebault C, Kane MS, Paris A, Alban J, Quiles M, Delettre C, Bonneau D, Procaccio V, Amati-Bonneau P, Reynier P, Leruez S, Calmon R, Boddaert N, Funalot B, Rio M, Bouccara D, Meunier I, Sesaki H, Kaplan J, Hamel CP, Rozet JM, Lenaers G (2017) Mutations in DNM1L, as in OPA1, result in dominant optic atrophy despite opposite effects on mitochondrial fusion and fission. Brain 140:2586\u20132596","journal-title":"Brain"},{"key":"425_CR8","doi-asserted-by":"crossref","unstructured":"Ham M, Han J, Osann K, Smith M, Kimonis V (2019) Meta-analysis of genotype-phenotype analysis of OPA1 mutations in autosomal dominant optic atrophy. Mitochondrion 46:262\u2013269","DOI":"10.1016\/j.mito.2018.07.006"},{"key":"425_CR9","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1093\/brain\/awm272","volume":"131","author":"G Hudson","year":"2008","unstructured":"Hudson G, Amati-Bonneau P, Blakely EL, Stewart JD, He L, Schaefer AM, Griffiths PG, Ahlqvist K, Suomalainen A, Reynier P, McFarland R, Turnbull DM, Chinnery PF, Taylor RW (2008) Mutation of OPA1 causes dominant optic atrophy with external ophthalmoplegia, ataxia, deafness and multiple mitochondrial DNA deletions: a novel disorder of mtDNA maintenance. Brain 131:329\u2013337","journal-title":"Brain"},{"key":"425_CR10","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1080\/13816810.2018.1466337","volume":"39","author":"H Li","year":"2018","unstructured":"Li H, Jones EM, Li H, Yang L, Sun Z, Yuan Z, Chen R, Dong F, Sui R (2018) Clinical and genetic features of eight Chinese autosomal-dominant optic atrophy pedigrees with six novel OPA1 pathogenic variants. Ophthalmic Genet 39:569\u2013576","journal-title":"Ophthalmic Genet"},{"key":"425_CR11","doi-asserted-by":"publisher","first-page":"e225","DOI":"10.1111\/aos.12038","volume":"91","author":"P Liskova","year":"2013","unstructured":"Liskova P, Ulmanova O, Tesina P, Melsova H, Diblik P, Hansikova H, Tesarova M, Votruba M (2013) Novel OPA1 missense mutation in a family with optic atrophy and severe widespread neurological disorder. Acta Ophthalmol 91:e225\u2013e231","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"425_CR12","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13023-017-0641-1","volume":"12","author":"A Nasca","year":"2017","unstructured":"Nasca A, Rizza T, Doimo M, Legati A, Ciolfi A, Diodato D, Calderan C, Carrara G, Lamantea E, Aiello C, Di Nottia M, Niceta M, Lamperti C, Ardissone A, Bianchi-Marzoli S, Iarossi G, Bertini E, Moroni I, Tartaglia M, Salviati L, Carrozzo R, Ghezzi D (2017) Not only dominant, not only optic atrophy: expanding the clinical spectrum associated with OPA1 mutations. Orphanet J Rare Dis 12(1):89. \n                    https:\/\/doi.org\/10.1186\/s13023-017-0641-1.","journal-title":"Orphanet J Rare Dis"},{"key":"425_CR13","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jns.2017.09.018","volume":"382","author":"E Pretegiani","year":"2017","unstructured":"Pretegiani E, Rosini F, Rufa A, Gallus GN, Cardaioli E, Da Pozzo P, Bianchi S, Serchi V, Collura M, Franceschini R, Bianchi Marzoli S, Dotti MT, Federico A (2017) Genotype-phenotype and OCT correlations in autosomal dominant optic atrophy related to OPA1 gene mutations: report of 13 Italian families. J Neurol Sci 382:29\u201335","journal-title":"J Neurol Sci"},{"key":"425_CR14","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1093\/brain\/awu378","volume":"138","author":"R Santarelli","year":"2015","unstructured":"Santarelli R, Rossi R, Scimemi P, Cama E, Valentino ML, La Morgia C, Caporali L, Liguori R, Magnavita V, Monteleone A, Biscaro A, Arslan E, Carelli V (2015) OPA1-related auditory neuropathy: site of lesion and outcome of cochlear implantation. Brain 138:563\u2013576","journal-title":"Brain"},{"key":"425_CR15","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1136\/jmedgenet-2015-103361","volume":"53","author":"R Spiegel","year":"2016","unstructured":"Spiegel R, Saada A, Flannery PJ, Burt\u00e9 F, Soiferman D, Khayat M, Eisner V, Vladovski E, Taylor RW, Bindoff LA, Shaag A, Mandel H, Schuler-Furman O, Shalev SA, Elpeleg O, Yu-Wai-Man P (2016) Fatal infantile mitochondrial encephalomyopathy, hypertrophic cardiomyopathy and optic atrophy associated with a homozygous OPA1 mutation. J Med Genet 53:127\u2013131","journal-title":"J Med Genet"},{"key":"425_CR16","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1093\/brain\/awq007","volume":"133","author":"P Yu-Wai-Man","year":"2010","unstructured":"Yu-Wai-Man P, Griffiths PG, Gorman GS, Lourenco CM, Wright AF, Auer-Grumbach M, Toscano A, Musumeci O, Valentino ML, Caporali L, Lamperti C, Tallaksen CM, Duffey P, Miller J, Whittaker RG, Baker MR, Jackson MJ, Clarke MP, Dhillon B, Czermin B, Stewart JD, Hudson G, Reynier P, Bonneau D, Marques WJ, Lenaers G, McFarland R, Taylor RW, Turnbull DM, Votruba M, Zeviani M, Carelli V, Bindoff LA, Horvath R, Amati-Bonneau P, Chinnery PF (2010) Multi-system neurological disease is common in patients with OPA1 mutations. Brain 133:771\u2013786","journal-title":"Brain"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-019-00425-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11011-019-00425-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-019-00425-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,30]],"date-time":"2020-05-30T23:15:51Z","timestamp":1590880551000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11011-019-00425-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,1]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["425"],"URL":"https:\/\/doi.org\/10.1007\/s11011-019-00425-0","relation":{},"ISSN":["0885-7490","1573-7365"],"issn-type":[{"value":"0885-7490","type":"print"},{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,1]]},"assertion":[{"value":"14 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"There are no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}